Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation

Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation

Background: Hypertriglyceridaemia (HTG) is an important risk factor for pancreatitis and cardiovascular disease (CVD), depending on severity. Hypertriglyceridaemia is common in human immunodeficiency virus (HIV) infection and is also a common complication of lopinavir/ritonavir (LPV/r). Objectives:...

Full description

Bibliographic Details
Main Authors: Wilhelm P. Greffrath, Jesslee M. du Plessis, Michelle Viljoen, Marike Cockeran
Format: Article
Language:English
Published: AOSIS 2018-06-01
Series:Southern African Journal of HIV Medicine
Subjects:
Hypertriglyceridaemia
pancreatitis
lopinavir/ritonavir
cardiovascular risk
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/766

Internet

https://sajhivmed.org.za/index.php/hivmed/article/view/766

Similar Items